01
Research-question review
We define the protein, biological system, existing anchoring evidence, required structural depth, and the downstream decision.
Glycosylphosphatidylinositol Anchor Analysis Service
Glycosylphosphatidylinositol (GPI) Anchor Analysis Service
Creative Biolabs provides GPI anchor analysis integrating release behavior, protein context, glycan evidence, and lipid characterization to support confident, structure-aware assignments.
Service Overview
Creative Biolabs supports researchers who need to distinguish a true GPI-anchored protein from a generally membrane-associated protein, or who need deeper evidence about anchor glycan and lipid composition. Our GPI anchor analysis service is positioned within the broader glycolipid analysis service and is scoped around the customer’s required level of assignment: confirmation, released-anchor characterization, or integrated structural interpretation.
The first project question is therefore not simply whether a GPI anchor may be present. It is what evidence will be sufficient for the downstream study. A screening project may focus on enzyme-sensitive release and membrane redistribution, whereas a structure-focused project may need anchor-specific fragments, glycan-core signals, lipid remodeling information, and protein C-terminal context.
Challenges in GPI-Anchor Characterization
GPI anchors combine a conserved core with variable lipid remodeling, side-chain substitutions, and protein-specific attachment. Their amphiphilic nature complicates recovery and detection. In addition, the same sample may contain N-glycans, O-glycans, phospholipids, detergents, and noncovalently associated membrane proteins that generate overlapping analytical signals.
- Low abundance and recovery: The anchored species may represent a small fraction of total protein, and losses can occur during membrane preparation, enrichment, enzymatic release, or cleanup.
- Anchor heterogeneity: Fatty-acyl composition, inositol acylation, and glycan side groups can vary by cell type, species, and biosynthetic state.
- Release-dependent bias: PI-PLC sensitivity is informative, but resistance can reflect inositol acylation, steric access, or incomplete digestion rather than absence of a GPI anchor.
- Mixed structural layers: Protein identity, the omega-site region, glycan core, and lipid moiety answer different questions and may require complementary evidence.
- Interpretation controls: Untreated controls, matched membrane fractions, non-GPI membrane proteins, and known GPI-anchored comparators help define what each signal can establish.
Our GPI Anchor Analysis Services
We organize the service around the assignment depth and available material. Individual modules may be combined, narrowed, or staged after an initial feasibility review.
GPI-Anchor Confirmation
Confirmation may combine a release experiment with orthogonal evidence from protein enrichment, membrane and supernatant fractions, C-terminal peptide information, or anchor-related mass signals. The strongest design uses controls that distinguish GPI-dependent release from nonspecific solubilization. When complete release is not expected, the interpretation can focus on a reproducible shift supported by additional anchor evidence rather than a binary positive or negative result.
Glycan and Lipid Moiety Characterization
Characterization depth depends on whether the customer needs composition-level information, selected structural features, or a more complete anchor assignment. Glycan-core and lipid analyses are related but not interchangeable. Core and lipid signals can support different parts of the assignment without resolving every substituent or position.
| Service Module | Research Question | Typical Evidence |
|---|---|---|
| GPI-anchor confirmation | Is the protein behavior consistent with covalent GPI anchoring? | Release-dependent redistribution, enrichment behavior, anchor-associated fragments, and matched controls. |
| Released-product analysis | What anchor-derived components are recovered after enzymatic or chemical treatment? | Released protein or anchor fragments, comparative profiles, and treatment-versus-control data. |
| Glycan-core characterization | Which conserved or modified carbohydrate features support the assignment? | Core-related compositions, fragment ions, and comparison with expected GPI structural motifs. |
| Lipid-moiety characterization | Which lipid classes or acyl-chain features are associated with the anchor? | Lipid-related masses or fragments, with confidence limited by recovery, ionization, and standards. |
| Integrated structural interpretation | How do protein, glycan, lipid, and release data fit together? | A layered conclusion with evidence strength, alternatives, and unresolved structural positions. |
What Can Each Level of GPI Analysis Establish?
The useful endpoint differs by project. Release behavior, protein context, glycan evidence, and lipid evidence address distinct questions, so we define the required conclusion before selecting analytical depth.
| Evidence Level | Reasonable Conclusion |
|---|---|
| Release / redistribution | Behavior consistent with GPI-dependent membrane attachment, interpreted with treatment and comparator controls. |
| Protein and C-terminal evidence | Supports protein identity and attachment-site context without, by itself, defining anchor microheterogeneity. |
| GPI glycan evidence | Supports anchor-core composition or remodeling features when glycan-bearing material can be recovered and assigned. |
| Lipid evidence | Supports lipid composition or remodeling features within the recovery, ionization, and reference limits of the method. |
| Integrated evidence | Combines orthogonal observations into a higher-confidence structural interpretation with unresolved alternatives stated. |
| Complete positional or isomeric structure | Only supported when the required structural evidence, standards, and resolving methods are available. |
For a broader overview of anchor structure, evidence layers, and method selection, see our GPI Anchor Analysis Guide.
Our Analytical Workflow
The collaboration proceeds through defined stages, while analytical details remain adjustable as early evidence clarifies sample behavior.
02
Sample and method fit
Purity, matrix, detergent or buffer composition, abundance, and available controls are reviewed before selecting enrichment or release conditions.
03
Anchor-focused preparation
The project may use membrane fractionation, selective enrichment, enzymatic release, targeted cleanup, or a combination appropriate to the sample.
04
Analytical acquisition
Protein, glycan, lipid, or fragment-level measurements are collected according to the agreed evidence plan, with treatment and comparator controls where relevant.
05
Integrated reporting
Results are assembled into a layered interpretation that separates direct observations, supported assignments, alternative explanations, and recommended follow-up.
Sample Requirements and Deliverables
Material requirements depend on abundance, matrix, purity, and whether the study stops at confirmation or proceeds to structural characterization. Early scoping helps preserve scarce material.
Project Input
Sample Requirements
Supports attachment-site context, peptide planning, and interpretation of C-terminal evidence.
Provides biological context for GPI biosynthesis, remodeling, and expected heterogeneity.
Determines compatibility with release, enrichment, chromatography, and mass spectrometry.
Enables treatment-control, GPI-deficient, non-GPI membrane-protein, or condition-based comparisons.
Defines whether the deliverable should emphasize confirmation, comparative profiling, or structure-aware assignment.
Project Output
Deliverables and Validation Scope
Sample handling, treatment, enrichment, and analytical conditions used.
Profiles, spectra, tables, or comparative results appropriate to the selected analytical modules.
Evidence level, confidence, and relevant alternative interpretations stated.
Included when part of the project design.
Conclusions, limitations, and suitable next analyses without presenting one route as universal.
Layered Evidence for GPI-Anchor Assignment
No single observation answers every GPI question. Release behavior, protein identification, C-terminal context, and glycan or lipid evidence address different layers of the assignment. Agreement across layers is stronger than treating one assay as definitive.
Controls define the boundaries. Treatment-related release alone does not establish anchor structure, and enzyme resistance does not exclude GPI anchoring. We report direct observations separately from structural inference so follow-up can target the unresolved layer.
Research Applications
GPI-Anchored Protein Confirmation
Tests whether membrane localization and release behavior are consistent with a covalent GPI anchor.
GPI Biosynthesis and Remodeling Research
Compares anchor-associated features across genetic, cellular, or culture conditions.
Engineered Protein Characterization
Examines whether a designed GPI signal produces the intended membrane attachment and anchor-associated evidence.
Mechanism and Disease-Model Research
Connects changes in anchoring, release, or remodeling to a defined experimental model without making clinical claims.
Published Data
Selective Enrichment of Cell-Surface GPI-Anchored Proteins
Cortes and colleagues developed two glycan-based enrichment strategies for proteomic identification of GPI-anchored proteins (GPI-APs) directly from intact mammalian cell surfaces. Following PI-PLC-mediated release, GPI-APs were enriched either through metabolic incorporation of the azido sugar analog GalNAz followed by covalent capture on alkyne resin, or through affinity capture with ConA and WGA lectins. The enriched proteins were subsequently digested and identified by LC-MS/MS. Both approaches increased detection of low-abundance GPI-APs while avoiding disruption of cellular membranes, and PI-PLC treatment produced at least threefold enrichment over untreated controls. The workflow was also applied to polarized epithelial cells, allowing GPI-AP populations at apical and basolateral membrane surfaces to be examined separately. This study illustrates how selective enzymatic release, glycan-directed enrichment, and proteomic identification can be integrated when direct analysis is limited by low abundance and membrane complexity.
Structural Analysis of the GPI Glycan
Nakano and colleagues described a mass-spectrometric workflow for direct structural characterization of the GPI glycan attached to an individual GPI-anchored protein. Gas1-GFP was enzymatically released from yeast membranes with PI-PLC, immunopurified, separated by SDS-PAGE, digested with trypsin, and analyzed by LC-MS and MS/MS. Extracted-ion chromatograms and a GPI-specific fragment ion were used to identify glycan-bearing peptides, while tandem mass spectra supported structural assignment of the remodeled anchor. Three GPI-glycan forms were detected, with approximately 94% of the analyzed glycopeptides corresponding to the predominant remodeled structure. Fragmentation evidence indicated addition of a fifth mannose and removal of ethanolamine phosphate groups from Man1 and Man2 during transport toward the plasma membrane. The study demonstrates why direct glycopeptide and MS/MS evidence is important for defining GPI-glycan composition and remodeling rather than inferring anchor structure from enzymatic release alone.
Mass-Spectrometric Analysis of GPI-Anchor Lipids
Aguilera-Romero and colleagues established a targeted mass-spectrometric method for determining the lipid composition of an individual GPI anchor. Gas1-GFP was isolated from yeast membranes by detergent solubilization and immunopurification, separated by SDS-PAGE, transferred to PVDF, and treated with nitrous acid to separate the protein and GPI-glycan portion from the inositol-containing lipid. The released GPI lipid was extracted and analyzed by negative-ion ESI-MS/MS using multiple-reaction monitoring (MRM). The method identified an inositolphosphoceramide containing phytosphingosine and a saturated C26 fatty acid in the Gas1-GFP anchor. Because MRM relies on predefined precursor/product ion pairs, the authors emphasized its selectivity for known candidate lipid species while noting that nontargeted profiling is more appropriate for uncharacterized anchors. These findings demonstrate that GPI-lipid composition represents a distinct analytical layer that complements glycan structural analysis and protein-level GPI-anchor identification.
Discuss Your GPI-Anchor Analysis Requirements
For project scoping, please share the protein or construct sequence, expected GPI signal or omega-site information, source and expression system, sample form and purity, buffer or detergent, available controls, sample number, and required evidence level. We will align the analytical modules with the material and research objective.
Frequently Asked Questions
Can GPI anchoring be confirmed without complete structural characterization?
Yes. A focused project can combine release-treated and
untreated fractions with protein detection, enrichment behavior, or another orthogonal readout. This can
support an anchoring assignment without resolving every glycan and lipid feature. The report will state the
evidence level and distinguish confirmation from complete structural characterization.
What if the protein is resistant to PI-PLC release?
PI-PLC resistance does not automatically exclude a GPI anchor.
Inositol acylation, steric shielding, membrane context, or incomplete digestion can reduce release.
Alternative release approaches, enrichment, C-terminal evidence, or anchor-related fragments may be
considered, with interpretation based on the combined observations rather than a single negative result.
Can purified protein and membrane samples both be analyzed?
Both can be considered, but they answer different questions.
Purified protein may simplify structural analysis if the anchor is retained, whereas membrane preparations
preserve biological context but introduce more lipids, detergents, and proteins. The preferred starting
material depends on abundance, purity, anchor integrity, and the requested analytical depth.
How is a GPI-anchored protein distinguished from a transmembrane protein?
The distinction can use release behavior, partitioning or
enrichment characteristics, sequence context, C-terminal peptide evidence, and anchor-associated glycan or
lipid signals. A non-GPI membrane-protein control is useful because general membrane solubilization may mimic
release. Confidence increases when several independent observations support the same assignment.
Can the lipid moiety of the GPI anchor be characterized?
Lipid-focused analysis may provide class, chain, or remodeling
information when anchor-derived material can be recovered and detected. Resolution depends on sample amount,
structural heterogeneity, standards, and ionization. Some projects yield composition-level evidence rather
than a complete positional structure, and this boundary is stated in the report.
What information is most useful before starting the project?
Please provide sequence and construct information, source
organism, expression system, sample form, buffer or detergent, estimated concentration and purity, existing
anchoring evidence, available controls, and the desired conclusion. Creative Biolabs uses these details to
scope a research-use analysis. For Research Use Only. Not For Clinical Use.
References
- Cortes, Leslie K., et al. “Proteomic Identification of Mammalian Cell Surface-Derived Glycosylphosphatidylinositol-Anchored Proteins through Selective Glycan Enrichment.” Proteomics 14.21-22 (2014): 2471-2484. Distributed under Open Access license CC BY 3.0, without modification. https://doi.org/10.1002/pmic.201400148.
- Nakano, Miyako, et al. “Structural Analysis of the GPI Glycan.” PLOS ONE 16.9 (2021): e0257435. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1371/journal.pone.0257435.
- Aguilera-Romero, Auxiliadora, et al. “Determination of the Lipid Composition of the GPI Anchor.” PLOS ONE 16.8 (2021): e0256184. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1371/journal.pone.0256184.
Project Inquiry
For Research Use Only. Not For Clinical Use.
Loading case studies...
Online Inquiry